Finance

Beta
Lists
WHWK:NASDAQ
Whitehawk Therapeutics Inc
$4.15
+3.23%
(+0.13) 1D
$4.15
0.00% (0.00)
After hours
Closed: Jul 7, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for WHWK...
Open
$4.04
High
$4.40
Low
$3.73
Mkt. cap
223.20M
Avg. vol.
490.65K
Volume
1.04M
52-wk high
$5.50
52-wk low
$1.57
EPS
-$3.59
Beta
0.77
Shares outstanding
53.78M
No. of employees
29
Open
$4.04
High
$4.40
Low
$3.73
Mkt. cap
223.20M
Avg. vol.
490.65K
Volume
1.04M
52-wk high
$5.50
52-wk low
$1.57
EPS
-$3.59
Beta
0.77
Shares outstanding
53.78M
No. of employees
29
News stories
From sources across the web
About Whitehawk Therapeutics Inc
CEO-
Employees29
Founded2007
Headquarters-
SectorBiotechnology
Websiteir.whitehawktx.com
Analyst ratings
Based on 6 analysts giving stock ratings to WHWK in the past 3 months
Buy
Buy
4
Hold
2
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for WHWK in the last 3 months.
Highest
Current $4.15
$10.00 (+140.96%)
Average
$8.00 (+92.77%)
Lowest
$7.00 (+68.67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yuan Zhi
B. Riley Securities
Buy
Initiated
$10.00
+141%
06/25/2026
Boris Peaker
JonesTrading
Buy
Maintained
$7.00
+68.7%
05/22/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
$7.00
+68.7%
05/08/2026
Tara Bancroft
TD Cowen
Hold
Maintained
-
-
05/07/2026
Robert Burns
H.C. Wainwright
Hold
Reiterated
-
-
04/21/2026
Reni Benjamin
Citizens JMP
Buy
Initiated
$8.00
+92.8%
04/16/2026
Soumit Roy
JonesTrading
Buy
Maintained
$7.00
+68.7%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
48.81M
14.34M
19.02M
17.23M
Cost of revenue
48.81M
14.34M
19.02M
17.23M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.94M
5.20M
5.87M
6.29M
Operating expense
5.94M
5.20M
5.87M
6.29M
Total operating expenses
54.75M
19.55M
24.89M
23.52M
Operating income
-54.75M
-19.55M
-24.89M
-23.52M
Other non operating income
158.00K
127.00K
17.00K
-
EBT including unusual items
-52.62M
-17.75M
-23.25M
-22.19M
EBT excluding unusual items
-52.62M
-17.57M
-23.25M
-22.19M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-52.62M
-17.75M
-23.25M
-22.19M
Net profit margin
-
-
-
-
Earnings per share
-0.76
-0.25
-0.34
-0.32
Interest and investment income
1.98M
1.85M
1.61M
1.33M
Interest expense
-
-
-
-
Net interest expenses
1.98M
1.85M
1.61M
1.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
-54.73M
-19.54M
-24.89M
-23.52M
Gain or loss from assets sale
-
177.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer